Table 2

Mean improvements from baseline until 3-month and 6-month follow-up, adjusted for age, gender and the respective baseline values

Component summary/scale scoreAdjusted analyses, mean change (95% CI) from baseline until 3 months*P values
RAPsA
PCS4.7 (4.3 to 5.0) n=30814.4 (3.9 to 4.9) n=11830.42
MCS1.8 (1.4 to 2.1) n=30811.5 (1.0 to 2.0) n=11830.41
SF-6D0.04 (0.03 to 0.04) n=23230.03 (0.03 to 0.04) n=8720.06
Physical functioning4.6 (4.2 to 5.0) n=31974.6 (4.2 to 5.2) n=12170.93
Role physical4.2 (3.8 to 4.6) n=31784.3 (3.7 to 4.8) n=12080.83
Bodily pain5.8 (5.5 to 6.1) n=31875.1 (4.6 to 5.5) n=12140.004
General health1.4 (1.1 to 1.7) n=31491.3 (0.9 to 1.7) n=12030.61
Vitality3.8 (3.5 to 4.2) n=31732.8 (2.3 to 3.4) n=12090.002
Social functioning3.7 (3.3 to 4.1) n=32013.3 (2.8 to 3.9) n=12160.31
Role emotional2.2 (1.8 to 2.7) n=31612.8 (2.1 to 3.4) n=11970.20
Mental health2.5 (2.2 to 2.8) n=31701.9 (1.4 to 2.4) n=12100.008